Literature DB >> 23447823

Mutation screening for KRAS and BRAF in metastatic colorectal cancer proves costly in relation to benefits.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23447823

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  1 in total

1.  Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran.

Authors:  Roya Dolatkhah; Mohammad Hossein Somi; Iraj Asvadi Kermani; Morteza Bonyadi; Bita Sepehri; Kamal Boostani; Saleh Azadbakht; Nikou Fotouhi; Faris Farassati; Saeed Dastgiri
Journal:  Onco Targets Ther       Date:  2016-12-07       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.